Instaray Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 5 Year, 4 Months
- Last Filing with ROC 07 Sep 2024
- Revenue %
(FY 2023)
- Profit 16.37%
(FY 2023)
- Ebitda 16.37%
(FY 2023)
- Net Worth -87.06%
(FY 2023)
- Total Assets 26.82%
(FY 2023)
About Instaray Lifescience
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 07 September 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Rangnath, Dhananjay Singh, Anju Yadav, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909MH2019PTC329477
- Company No.
329477
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
07 Sep 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Instaray Lifescience?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Rangnath  | Director | 20-Aug-2019 | Current |
| Dhananjay Singh | Director | 20-Aug-2019 | Current |
| Anju Yadav | Director | 20-Aug-2019 | Current |
| Archana Pandey | Director | 20-Aug-2019 | Current |
Financial Performance of Instaray Lifescience.
Instaray Lifescience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 16.37% increase in profit. The company's net worth observed a substantial decline by a decrease of 87.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Instaray Lifescience?
In 2023, Instaray Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Instaray Pharmaceuticals LlpActive 8 years 7 daysSudhir Rangnath, Dhananjay Singh and 2 more are mutual person
- Do5ine Techno India Private LimitedActive 9 months 16 days
Sudhir Rangnath and Dhananjay Singh are mutual person
- Bioquell Pharma Private LimitedActive 3 months 27 days
Sudhir Rangnath and Dhananjay Singh are mutual person
- Instaray Healthcare Private LimitedActive 7 years 4 months
Sudhir Rangnath and Dhananjay Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Instaray Lifescience?
Unlock and access historical data on people associated with Instaray Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Instaray Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Instaray Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
